BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37147666)

  • 1. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
    Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
    Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour suppressor ABCA8 inhibits malignant progression of colorectal cancer via Wnt/β-catenin pathway.
    Yang K; Li X; Jiang Z; Li J; Deng Q; He J; Chen J; Li X; Xu S; Jiang Z
    Dig Liver Dis; 2024 May; 56(5):880-893. PubMed ID: 37968146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of ADAM 12 Regulates Epithelial-mesenchymal Transition by Activating the Wnt/β-catenin Signaling Pathway in Colorectal Cancer.
    Huang C; Wang J; Xiang J; Wu C; Wang F; Chen J; Sun G; Xiang D
    Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38716545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells.
    Sun L; Xing J; Zhou X; Song X; Gao S
    Biomed Pharmacother; 2024 Jun; 175():116685. PubMed ID: 38710151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of BZW1 promotes invasion and metastasis of gastric cancer cells by regulating Wnt/β-catenin signaling and promoting epithelial-mesenchymal transition].
    Zhang W; Zhang N; Yang Z; Zhang X; Sun A; Wang L; Song X; Geng Z; Li J; Hu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):354-362. PubMed ID: 38501421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
    Yang Y; Yuan Y; Xia B
    Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
    Shome R; Sen P; Sarkar S; Ghosh SS
    Exp Cell Res; 2024 May; 438(1):114032. PubMed ID: 38583856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway.
    Yu P; Xu T; Ma W; Fang X; Bao Y; Xu C; Huang J; Sun Y; Li G
    J Exp Clin Cancer Res; 2024 Apr; 43(1):116. PubMed ID: 38637831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the Wnt/β-catenin pathway.
    Li J; Li S; Xing X; Liu N; Lai S; Liao D; Li J
    Biotechnol Appl Biochem; 2024 Apr; 71(2):245-255. PubMed ID: 37983718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
    Liu Y; Qin Z; Yang K; Liu R; Xu Y
    Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells.
    Wu Z; Zhou S; Liang D; Mu L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1115-1125. PubMed ID: 37610461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis.
    Wang Y; Cao Y; Chen Y; Cheng H; Liu Z; Wang M; Feng Y; Fei B; Cui K; Huang Z
    Med Oncol; 2024 Mar; 41(5):100. PubMed ID: 38538804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab inhibits colorectal cancer development through inactivating the Wnt/β-catenin pathway and modulating PLCB3 expression.
    Zhang X; Zhou W; Wu C; Jiang J; Guo Q; Feng L; Cheng X; Zhang X
    Sci Rep; 2024 May; 14(1):10642. PubMed ID: 38724565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
    Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Lichong decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt/β-catenin signaling pathway.
    Liu L; Zhao M; Lang X; Jia S; Kang X; Liu Y; Liu J
    J Cancer Res Clin Oncol; 2024 May; 150(5):234. PubMed ID: 38710918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck.
    Yuan W; Hu J; Wang M; Li G; Lu S; Qiu Y; Liu C; Liu Y
    Mol Carcinog; 2024 May; 63(5):885-896. PubMed ID: 38353298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP12 downregulates the Wnt/β-catenin pathway via interaction with STK38 to suppress colorectal cancer.
    Khan S; Kwak YT; Peng L; Hu S; Cantarel BL; Lewis CM; Gao Y; Mani RS; Kanneganti TD; Zaki H
    J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37581937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.